Standardized approach to removal of lumen apposing metal stents following endoscopic necrosectomy: one size does not fit all.

IF 3.9 3区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Therapeutic Advances in Gastroenterology Pub Date : 2025-03-31 eCollection Date: 2025-01-01 DOI:10.1177/17562848251320739
Robert Dorrell, Alexa Cecil, Swati Pawa, Gregory Russell, Rishi Pawa
{"title":"Standardized approach to removal of lumen apposing metal stents following endoscopic necrosectomy: one size does not fit all.","authors":"Robert Dorrell, Alexa Cecil, Swati Pawa, Gregory Russell, Rishi Pawa","doi":"10.1177/17562848251320739","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Walled-off necrosis (WON) is a sequela of acute necrotizing pancreatitis preferentially managed with lumen apposing metal stents (LAMS). Adverse events including buried stent syndrome and bleeding have been associated with a longer duration of LAMS placement.</p><p><strong>Objectives: </strong>We attempt to examine our outcomes of a standardized approach to LAMS dwell time and hypothesize that LAMS removal based on imaging characteristics and patient symptoms improves outcomes.</p><p><strong>Design: </strong>From November 2015 to May 2022, a prospectively maintained database on patients with symptomatic WON undergoing endoscopic drainage with LAMS was retrospectively reviewed and analyzed.</p><p><strong>Methods: </strong>Patient characteristics, procedure details, and outcomes were recorded. Imaging was performed at 1, 3, and 6 weeks after LAMS placement and 1 week after each necrosectomy. Imaging findings and patient symptoms were used to determine the need for repeat necrosectomy. The timing of LAMS removal was guided by adequate endoscopic necrosectomy and resolution of the patient's symptoms. Subgroups were identified based on the duration of LAMS placement (less than 4 weeks and more than 4 weeks). Independent <i>t</i>-tests (continuous variables) and Fisher's exact tests (categorical outcomes) were used to analyze the two groups.</p><p><strong>Results: </strong>In all, 104 patients underwent endoscopic necrosectomy during the study period. Of the two subgroups identified based on LAMS dwell time, 70 patients had a LAMS duration greater than 4 weeks and 34 patients had a LAMS duration less than 4 weeks. Collections with >50% necrosis were more commonly seen in patients with longer LAMS dwell time (<4 weeks (12%) vs >4 weeks (33%), <i>p</i> = 0.031). The median number of necrosectomies was fewer in the early LAMS removal group compared to the late LAMS removal cohort (<i>p</i> = 0.03). Clinical outcomes including technical success, clinical success, delayed adverse events, and 6-month mortality were similar in both groups.</p><p><strong>Conclusion: </strong>A patient-specific customized approach to endoscopic drainage of WON improves outcomes. Patients with extensive necrosis may require a longer LAMS dwell time to achieve adequate debridement and clinical resolution. An increased risk of bleeding or adverse events related to prolonged duration of LAMS placement was not observed in our study. Future larger prospective studies are needed to confirm these conclusions.</p>","PeriodicalId":48770,"journal":{"name":"Therapeutic Advances in Gastroenterology","volume":"18 ","pages":"17562848251320739"},"PeriodicalIF":3.9000,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11956515/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Gastroenterology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17562848251320739","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Walled-off necrosis (WON) is a sequela of acute necrotizing pancreatitis preferentially managed with lumen apposing metal stents (LAMS). Adverse events including buried stent syndrome and bleeding have been associated with a longer duration of LAMS placement.

Objectives: We attempt to examine our outcomes of a standardized approach to LAMS dwell time and hypothesize that LAMS removal based on imaging characteristics and patient symptoms improves outcomes.

Design: From November 2015 to May 2022, a prospectively maintained database on patients with symptomatic WON undergoing endoscopic drainage with LAMS was retrospectively reviewed and analyzed.

Methods: Patient characteristics, procedure details, and outcomes were recorded. Imaging was performed at 1, 3, and 6 weeks after LAMS placement and 1 week after each necrosectomy. Imaging findings and patient symptoms were used to determine the need for repeat necrosectomy. The timing of LAMS removal was guided by adequate endoscopic necrosectomy and resolution of the patient's symptoms. Subgroups were identified based on the duration of LAMS placement (less than 4 weeks and more than 4 weeks). Independent t-tests (continuous variables) and Fisher's exact tests (categorical outcomes) were used to analyze the two groups.

Results: In all, 104 patients underwent endoscopic necrosectomy during the study period. Of the two subgroups identified based on LAMS dwell time, 70 patients had a LAMS duration greater than 4 weeks and 34 patients had a LAMS duration less than 4 weeks. Collections with >50% necrosis were more commonly seen in patients with longer LAMS dwell time (<4 weeks (12%) vs >4 weeks (33%), p = 0.031). The median number of necrosectomies was fewer in the early LAMS removal group compared to the late LAMS removal cohort (p = 0.03). Clinical outcomes including technical success, clinical success, delayed adverse events, and 6-month mortality were similar in both groups.

Conclusion: A patient-specific customized approach to endoscopic drainage of WON improves outcomes. Patients with extensive necrosis may require a longer LAMS dwell time to achieve adequate debridement and clinical resolution. An increased risk of bleeding or adverse events related to prolonged duration of LAMS placement was not observed in our study. Future larger prospective studies are needed to confirm these conclusions.

求助全文
约1分钟内获得全文 求助全文
来源期刊
Therapeutic Advances in Gastroenterology
Therapeutic Advances in Gastroenterology GASTROENTEROLOGY & HEPATOLOGY-
CiteScore
6.70
自引率
2.40%
发文量
103
审稿时长
15 weeks
期刊介绍: Therapeutic Advances in Gastroenterology is an open access journal which delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of gastrointestinal and hepatic disorders. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in gastroenterology and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area. The editors welcome original research articles across all areas of gastroenterology and hepatology. The journal publishes original research articles and review articles primarily. Original research manuscripts may include laboratory, animal or human/clinical studies – all phases. Letters to the Editor and Case Reports will also be considered.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信